- Lobbying
- Kristen AND Shatynski
Lobbying Arrangements Results for 'Kristen Shatynski'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Value of prescription drugs Issues related to Medicare Parts B & D Implementation of P.L. 117-169, Inflation Reduction Act of 2022 SUPPORT Act reauthorization (H.R. 4490, and H.R.4531/S.3393, the ... |
Johnson & Johnson Services, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry |
Anheuser-Busch Companies
|
SPLITOAK STRATEGIES LLC | |||
Details Value of prescription drugs and patient access Issues related to Medicare Parts B & D Implementation of P.L. 117-659 (H.R.5376) - Inflation Reduction Act |
Bristol-Myers Squibb
|
SPLITOAK STRATEGIES LLC | |||
Details Extension of Acute Hospital Care at Home waiver program; Discussion draft of Rep. Wenstrup/Rep. Blumenauer, Hospital Inpatient Services Modernization Act |
Advanced Care at Home (ACH) Coalition
|
SPLITOAK STRATEGIES LLC | |||
Details Value of coordination and management in providing high quality, efficient health care coverage |
UnitedHealth Group
|
SPLITOAK STRATEGIES LLC | |||
Details Research, education and public health surveillance of kidney disease; Living Donor Protection Act H.R.2923/S.1384 |
American Kidney Fund
|
SPLITOAK STRATEGIES LLC | |||
Details Ensuring access to treatments for rare disease; Value of rare disease research and development; FDA process improvements for rare disease; Improving access for patients with orphan diseases; Improv... |
Amryt Pharma
|
SPLITOAK STRATEGIES LLC | |||
Details HR 5397 the Joe Fiandra Access to Home Infusion Act, Issues related to patient access to rare disease therapies, HR 2882 Further Consolidated Appropriations Act of 2024, HR 4366 the Consolidated Ap... |
Chiesi USA, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; S.476/H.R.5547, Maintaining Investments in New Innovation Act; patient access to appro... |
Alnylam Pharmaceuticals, Inc.
|
SPLITOAK STRATEGIES LLC | |||
Details Access to preventative health; HR 5378 The Lower Costs, More Transparency Act to extend funding for Community Health Centers, Teaching Health Centers GME and the National Health Service Corps; Bipa... |
National Association of Community Health Centers
|
SPLITOAK STRATEGIES LLC | |||
Details Improve integration of behavioral health and primary care; advance value-based care; address workforce shortages and improve data collection under Graduate Medical Education program; adequate physi... |
American Academy of Family Physicians
|
SPLITOAK STRATEGIES LLC | |||
Details General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.4531/S.3393, the Support for Patients and Communities Rea... |
Bipartisan Policy Center Action
|
SPLITOAK STRATEGIES LLC |